Srd5a2 is the predominant isoform in the normal prostate; while the underlying mechanistic advantage is unclear, srd5a2 expression is downregulated in PCa while srd5a1 expression is upregulated63. The gene discussed is SRD5A2; the disease is posterior cortical atrophy.